BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8254399)

  • 1. Evaluation of experimental liver tumors using fluorine-18-2-fluoro-2-deoxy-D-glucose PET.
    Oya N; Nagata Y; Ishigaki T; Abe M; Tamaki N; Magata Y; Konishi J
    J Nucl Med; 1993 Dec; 34(12):2124-9. PubMed ID: 8254399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG-PET evaluation of therapeutic effects on VX2 liver tumor.
    Oya N; Nagata Y; Tamaki N; Takagi T; Murata R; Magata Y; Abe M; Konishi J
    J Nucl Med; 1996 Feb; 37(2):296-302. PubMed ID: 8667065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.
    Tatsumi M; Nakamoto Y; Traughber B; Marshall LT; Geschwind JF; Wahl RL
    Cancer Res; 2003 Oct; 63(19):6252-7. PubMed ID: 14559811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental study for cancer diagnosis with positron-labeled fluorinated glucose analogs: [18F]-2-fluoro-2-deoxy-D-mannose: a new tracer for cancer detection.
    Fukuda H; Matsuzawa T; Abe Y; Endo S; Yamada K; Kubota K; Hatazawa J; Sato T; Ito M; Takahashi T; Iwata R; Ido T
    Eur J Nucl Med; 1982; 7(7):294-7. PubMed ID: 6981508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of tumoricidal efficacy and response to treatment with 18F-FDG PET/CT after intraarterial infusion with the antiglycolytic agent 3-bromopyruvate in the VX2 model of liver tumor.
    Liapi E; Geschwind JF; Vali M; Khwaja AA; Prieto-Ventura V; Buijs M; Vossen JA; Ganapathy-Kanniappan S; Wahl RL
    J Nucl Med; 2011 Feb; 52(2):225-30. PubMed ID: 21233194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake.
    Kubota R; Kubota K; Yamada S; Tada M; Ido T; Tamahashi N
    J Nucl Med; 1994 Jan; 35(1):104-12. PubMed ID: 8271030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment.
    Okazumi S; Isono K; Enomoto K; Kikuchi T; Ozaki M; Yamamoto H; Hayashi H; Asano T; Ryu M
    J Nucl Med; 1992 Mar; 33(3):333-9. PubMed ID: 1311035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG-PET for evaluating the antitumor effect of intraarterial 3-bromopyruvate administration in a rabbit VX2 liver tumor model.
    Park HS; Chung JW; Jae HJ; Kim YI; Son KR; Lee MJ; Park JH; Kang WJ; Yoon JH; Chung H; Lee K
    Korean J Radiol; 2007; 8(3):216-24. PubMed ID: 17554189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits.
    Okuma T; Matsuoka T; Okamura T; Wada Y; Yamamoto A; Oyama Y; Koyama K; Nakamura K; Watanabe Y; Inoue Y
    J Nucl Med; 2006 Aug; 47(8):1351-8. PubMed ID: 16883016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDG-MicroPET and diffusion-weighted MR image evaluation of early changes after radiofrequency ablation in implanted VX2 tumors in rabbits.
    Ohira T; Okuma T; Matsuoka T; Wada Y; Nakamura K; Watanabe Y; Inoue Y
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):114-20. PubMed ID: 18696151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG.
    Kubota R; Kubota K; Yamada S; Tada M; Takahashi T; Iwata R; Tamahashi N
    J Nucl Med; 1995 Mar; 36(3):484-92. PubMed ID: 7884515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study for tumor detection using 18F-2-fluoro-deoxy-D-glucose: imaging of rabbit VX2-tumor with single photon gamma camera].
    Abe Y; Matsuzawa T; Fukuda H; Endo S; Yamada K; Sato T; Ito M; Kubota K; Hatazawa J; Yoshioka S
    Kaku Igaku; 1985 Mar; 22(3):389-91. PubMed ID: 3874982
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.
    Torizuka T; Tamaki N; Inokuma T; Magata Y; Sasayama S; Yonekura Y; Tanaka A; Yamaoka Y; Yamamoto K; Konishi J
    J Nucl Med; 1995 Oct; 36(10):1811-7. PubMed ID: 7562048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma.
    Yonekura Y; Benua RS; Brill AB; Som P; Yeh SD; Kemeny NE; Fowler JS; MacGregor RR; Stamm R; Christman DR; Wolf AP
    J Nucl Med; 1982 Dec; 23(12):1133-7. PubMed ID: 6982967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer: animal localization and initial patient positron emission tomography.
    Harney JV; Wahl RL; Liebert M; Kuhl DE; Hutchins GD; Wedemeyer G; Grossman HB
    J Urol; 1991 Feb; 145(2):279-83. PubMed ID: 1988718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy.
    Torizuka T; Tamaki N; Inokuma T; Magata Y; Yonekura Y; Tanaka A; Yamaoka Y; Yamamoto K; Konishi J
    J Nucl Med; 1994 Dec; 35(12):1965-9. PubMed ID: 7989978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography.
    Kubota R; Yamada S; Kubota K; Ishiwata K; Tamahashi N; Ido T
    J Nucl Med; 1992 Nov; 33(11):1972-80. PubMed ID: 1432158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.
    Schmidt K; Lucignani G; Moresco RM; Rizzo G; Gilardi MC; Messa C; Colombo F; Fazio F; Sokoloff L
    J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative PET imaging of experimental tumors with bromine-76-labeled antibodies, fluorine-18-fluorodeoxyglucose and carbon-11-methionine.
    Lövqvist A; Sundin A; Roberto A; Ahlström H; Carlsson J; Lundqvist H
    J Nucl Med; 1997 Jul; 38(7):1029-35. PubMed ID: 9225786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of 2-[18F]fluoro-2-deoxyglucose in tumor-bearing rats: chromatographic and enzymatic studies.
    Suolinna EM; Haaparanta M; Paul R; Härkönen P; Solin O; Sipilä H
    Int J Rad Appl Instrum B; 1986; 13(5):577-81. PubMed ID: 3818323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.